CATHEDRAL OF SAN LORENZO – FRIDAY 6 SEPTEMBER

17.30

Immune tolerance induction rescue (ITI-R) with human-cl rhFVIII in hemophilia A patients and high-titre inhibitors
S. Pasca (Italy)
VIEW ePOSTER

17.40

Usefulness of global haemostasis assays in haemophilia A patients with discrepant bleeding phenotype
M. Milos (Croatia)
VIEW ePOSTER

17.50

Visual inspection of the aPTT reaction curve as a reliable screening tool for detecting the presence of FVIII and FIX inhibitors
J. Pavic (Bosnia and Herzegovina)
VIEW ePOSTER

18.00

Comparison of the effect of cationic and anionic polyamidoamine dendrimers on components of coagulation system
Aisina R.B (Russia)
VIEW ePOSTER

18.10

Prospective Study Of The Immunological Response To Factor VIII In Severe Hemophilia A Patients During Immune Tolerance Induction Treatment
S. Rossini (Italy)
VIEW ePOSTER

18.20

Accurate factor FVIII concentrate dosing by ideal body weight in overweight and obese hemophilia A patients
T. Goedhart (The Netherlands)
VIEW ePOSTER

CATHEDRAL OF SAN LORENZO – SATURDAY 7 SEPTEMBER

18.30

The presence of anti-ADAMTS13 autoantibodies in immune-mediated thrombotic thrombocytopenic purpura patients does not hamper correct determination of ADAMTS13 antigen levels
C. Dekimpe (Belgium)
VIEW ePOSTER

18.40

Single-sample detection of anti-ADAMTS13 autoantibodies using fiber-optic surface plasmon resonance technology
C. Dekimpe (Belgium)
VIEW ePOSTER

18.50

BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease
F. Atiq (The Netherlands)
VIEW ePOSTER

19.00

Analytical Performance Validation of a new screening assay for the deficiency of ADAMTS-13 Activity
N. Binder (Austria)
VIEW ePOSTER

19.10

Feasibility of a new fully automated ADAMTS-13 activity assay
N. Binder (Austria)
VIEW ePOSTER